Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126226101 | 12622610 | 1 | I | 20160616 | 20160804 | 20160804 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-053694 | BRISTOL MYERS SQUIBB | 53.00 | YR | F | Y | 0.00000 | 20160804 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126226101 | 12622610 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Unknown | 300 MG, QD | Y | 21567 | 300 | MG | QD | ||||||
| 126226101 | 12622610 | 2 | SS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Unknown | 200 MG, UNK | Y | 21567 | 200 | MG | |||||||
| 126226101 | 12622610 | 3 | SS | DASABUVIR | DASABUVIR | 1 | Unknown | 250 MG, BID | U | 0 | 250 | MG | BID | ||||||
| 126226101 | 12622610 | 4 | SS | OMBITASVIR | OMBITASVIR | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 126226101 | 12622610 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 0 | ||||||||||
| 126226101 | 12622610 | 6 | SS | PARITAPREVIR | PARITAPREVIR | 1 | Unknown | U | 0 | ||||||||||
| 126226101 | 12622610 | 7 | SS | RITONAVIR. | RITONAVIR | 1 | Unknown | 1 DF, QD | Y | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126226101 | 12622610 | 1 | HIV infection |
| 126226101 | 12622610 | 3 | HIV infection |
| 126226101 | 12622610 | 4 | HIV infection |
| 126226101 | 12622610 | 5 | HIV infection |
| 126226101 | 12622610 | 6 | HIV infection |
| 126226101 | 12622610 | 7 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126226101 | 12622610 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126226101 | 12622610 | Drug interaction | |
| 126226101 | 12622610 | Hyperbilirubinaemia | |
| 126226101 | 12622610 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126226101 | 12622610 | 7 | 2009 | 0 |